Proposed Investment

Go-AI is a company based in Melbourne, Victoria.
Go-AI’s first business is dedicated to applying advanced medical engineering technologies to early detect and treat, and repurpose and develop immunotherapy drugs for treatment of Cancer Diseases with existing small molecule drugs.
We have placed 600,000 new shares at A$1.00 per share (First tranche Offer) to raise A$600,000 to fund our business development, finance overheads and prepare for a stock exchange listing. Refer to next slide: Capital Management Plan.
This first placement now completed represents about 0.5% of expanded issued capital of 100.6 million shares. (Link: Share placement application)

Capital Management Plan*

For Professional & Sophisticated Investors

First tranche Offer: 600,000 shares at A$1 per share. (Closed)
Second tranche Offer: 500,000 shares at A$2 per share.
Third tranche Offer: pre IPO 2 million shares at A$3 per share.
IPO at A$10 per share issuing an additional 2 million new shares at A$10 per share. Projected total IPO issued capital will be 105.1 million shares.

* Go-AI Pty Ltd reserves the absolute right to change its Capital Management Plan as to price, quantity and timing of securities to be offered prior to each tranche of the Offer.

Proposed Investment

For Professional & Sophisticated Investors

Address

Contacts

Links